Navigation Links
Luminex Corporation Second Quarter Earnings Release Scheduled for August 3, 2015
Date:7/13/2015

AUSTIN, Texas, July 13, 2015 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the second quarter ended June 30, 2015 on Monday, August 3, 2015. A press release announcing the results is scheduled for release after the close of trading.

Management will hold a conference call to discuss the operating highlights and financial results for the second quarter ended June 30, 2015 on August 3, 2015, at 4:30 p.m. Eastern time.

The conference call will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the website, go to the About Us section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the call to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the call will be archived for six months on the website using the 'replay' link.

The use of pop-up blocking software may impair your ability to view webcasts. If you use this software, press and hold the CTRL key when you click on the Register button. Please contact your IT group if you are unable to override this feature. Unauthorized recording or downloading of this event is not permitted.

About Luminex Corporation

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com.

Luminex Corporate Contact:
Harriss Currie, 512.219.8020
Sr. Vice President, Finance and CFO
hcurrie@luminexcorp.com

Luminex Investor Contact:
Matthew Scalo, 512.219.8020
Sr. Director, Investor Relations
mscalo@luminexcorp.com

Logo - http://photos.prnewswire.com/prnh/20150201/172702LOGO

 


'/>"/>
SOURCE Luminex Corporation
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement
2. Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporations xMAP Technology
3. Luminex Corporation Second Quarter Earnings Release Scheduled for July 29, 2013
4. Luminex Corporation Achieves Milestone, Ships 10,000th Instrument
5. Luminex Corporation Reports Second Quarter 2013 Results
6. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
7. LUMINEX CORPORATION TO HOST INVESTOR EVENT AT ASSOCIATION FOR MOLECULAR PATHOLOGY ANNUAL MEETING
8. Luminex Corporation Reports Third Quarter 2013 Results
9. Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014
10. Luminex Corporation Reports Second Quarter 2014 results
11. Luminex Is Supporting U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Research Efforts to Control African Ebola Outbreak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/15/2020)... ... February 14, 2020 , ... February is National ... organisms that cause inflammatory gum disease (e.g., periodontitis) and systemic inflammatory disease (e.g., ... new tools in the fight against common dental problems such as gum disease, ...
(Date:2/14/2020)... ... , ... Dignitana AB , world leader in scalp cooling innovation, announced ... three signature events in 2020 with Susan G. Komen®. The sponsorship extends Dignitana’s reach ... Cure® and MORE THAN PINK Walk® events in key Dignitana markets throughout year. , ...
(Date:2/14/2020)... ... February 14, 2020 , ... The ... Children’s Healthcare of Atlanta (Children’s) raised through their annual Holiday Giving Campaign. The ... new or pre-owned vehicle sales between November 29, 2019, through January 2, 2020, ...
Breaking Medicine Technology:
(Date:2/26/2020)... ... February 26, 2020 , ... ... company Transposagen (now a Hera BioLabs company) which is best known for its ... dual-guided CRISPR nickase systems as it is truly dimeric and demonstrates high fidelity ...
(Date:2/26/2020)... Calif. (PRWEB) , ... February 26, 2020 , ... Nutricare’s ... at Booth H213, where they'll be showcasing their pioneering line of compostable bamboo bandages ... our first time at Expo West, and we were blown away by the support ...
(Date:2/23/2020)... ... February 22, 2020 , ... Although many people thrive ... Queendom.com reveals that some people who dismiss compliments struggle with their sense ... 9,568 who took the Emotional Intelligence Test, Queendom researchers focused on ...
(Date:2/21/2020)... (PRWEB) , ... February 21, 2020 , ... Representatives with Bay-Bay Water today ... the launch of Bay-Bay Water’s new company logo as part of the ongoing evolution of ... come at a time when the company is expanding its national reach. , “We have ...
(Date:2/21/2020)... ... , ... The American Society for Clinical Pathology (ASCP) has ... in October 2021. The prestigious, invitation-only event—organized by the Union for International Cancer ... city and industry leaders, senior executives and other influential players from around ...
Breaking Medicine News(10 mins):